USA — Bayer and Hologic have joined forces with a singular mission: to revolutionize breast cancer scans. Their visionary approach combines Bayer’s cutting-edge imaging contrast agents with Hologic’s state-of-the-art mammography…
Read MoreTag: Cancer
Roche under fire for failing to include essential drug information, potentially putting patient safety at risk
UNITED KINGDOM — In a recent development, pharmaceutical giant Roche has found itself in hot water for omitting crucial safety information from a webpage dedicated to one of its cancer…
Read MoreModerna expands mRNA-based cancer research with US$1.8 billion deal with Immatics
USA — Moderna, the Massachusetts-based pioneer in mRNA technology, has entered into a substantial agreement worth up to US$1.8 billion with Immatics, a specialist in T-cell receptor (TCR) therapies. This…
Read MoreRwanda to unveil pioneering research institute against digestive cancer
RWANDA — Rwanda is on the verge of making medical history as it prepares to unveil Institute for Research into Cancer of the Digestive System Africa (ICARD Africa), the continent’s…
Read MoreGerman Development Cooperation and Bayer partner to combat prostate cancer in Ghana
GHANA — German Development Cooperation and Bayer Group have launched a prostate intervention project in the Greater Accra Region of Ghana. The initiative, spanning eight strategically selected district health facilities,…
Read MoreRoche faces delay in FDA decision for subcutaneous Tecentriq cancer immunotherapy
SWITZERLAND — Roche’s eagerly awaited subcutaneous version of its groundbreaking cancer immunotherapy Tecentriq may not receive its anticipated FDA decision on time. The FDA was set to deliver a verdict…
Read MoreMariana Oncology secures US$175 million in Series B round with Eli Lilly on board
FRANCE — Investors have demonstrated strong support for Mariana Oncology’s series B financing, with the round oversubscribed at a remarkable US$175 million. Notably, pharmaceutical giant Eli Lilly has joined this…
Read MoreUrgent action needed to prevent 70,000 cervical cancer deaths annually in Africa
BOTSWANA — In a critical call to action, health leaders and donors convened at the Seventy-third session of the World Health Organization (WHO) Regional Committee for Africa in Gaborone, Botswana,…
Read MoreMerck and Eisai’s combination therapy fails to boost overall survival in head and neck cancer study
USA —Merck & Co. and Eisai have revealed disappointing results from their clinical trial testing the combination of Lenvima (Lenvatinib) and Keytruda (pembrolizumab) in the treatment of recurrent or metastatic…
Read MoreNew Bayer survey exposes Americans’ cancer-related fears and knowledge gaps
USA — Bayer, the Germany-based pharmaceutical giant has delved into the American public’s sentiments regarding cancer awareness through a comprehensive survey conducted in collaboration with the Harris Poll. The results…
Read More